Prostate cancer poses significant burdens of mortality and morbidity on black men, greater than in while men, especially in the southeastern US. Prostate cancer in black men is diagnosed at a later state, with consequently a worse prognosis. This study will build on our previous studies on prostate cancer in elderly black men, and use similar methods to our study of rectal carcinoma. Our specific questions (controlling for potential confounders) are: 1) Do black men receive less aggressive treatment for localized prostate cancer than white men? 2) Do black men with prostate cancer have a history of less frequent screening with prostate specific antigen (PSA) and white men with prostate cancer? 3) Are knowledge, attitudes and beliefs regarding PSA screening and treatment different black and white men with prostate cancer? We will conduct a case-case study of 300 incident cancer among black men and 300 incident cases of prostate cancer among white men age 65 and older in a 33 county area of North Carolina. Cases will be identified from the North Carolina Central Cancer Registry. After obtaining permission from the patient's physician, we will obtain medical records and conduct a detailed telephone interview to assess demographics; income and poverty levels; education; level of social support; attitudes toward screening tests, especially cancer screening; access to health care; history of use of prostate and other screening tests compared with use of PSA as a diagnostic test; stage of cancer and types of treatments used. This study will determine: 1) whether initial treatment could account for these racial disparities in treatment outcomes, and 2) whether attitudes toward screening tests in general, and prostate cancer in particular, or other factors appear to explain these differences. This examination of the multiple possible factors for which race may serve as an indicator will substantially improve our understanding of racial disparities in prostate cancer, leading to targeted interventions.

Agency
National Institute of Health (NIH)
Institute
Agency for Healthcare Research and Quality (AHRQ)
Type
Research Program Projects (P01)
Project #
1P01HS010861-01
Application #
6368603
Study Section
Special Emphasis Panel (ZHS1-HCT-E (01))
Project Start
2000-09-15
Project End
2005-08-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2000
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Torrone, Elizabeth A; Levandowski, Brooke A; Thomas, James C et al. (2010) Identifying gaps in HIV prevention services. Soc Work Public Health 25:327-40
Do, Young Kyung; Carpenter, William R; Spain, Pamela et al. (2010) Race, healthcare access and physician trust among prostate cancer patients. Cancer Causes Control 21:31-40
Spain, Pamela; Carpenter, William R; Talcott, James A et al. (2008) Perceived family history risk and symptomatic diagnosis of prostate cancer: the North Carolina Prostate Cancer Outcomes study. Cancer 113:2180-7
Talcott, James A; Spain, Pamela; Clark, Jack A et al. (2007) Hidden barriers between knowledge and behavior: the North Carolina prostate cancer screening and treatment experience. Cancer 109:1599-606
Carey, Timothy S; Howard, Daniel L; Goldmon, Moses et al. (2005) Developing effective interuniversity partnerships and community-based research to address health disparities. Acad Med 80:1039-45
Chen, Ian; Kurz, James; Pasanen, Mark et al. (2005) Racial differences in opioid use for chronic nonmalignant pain. J Gen Intern Med 20:593-8